Compare BNR & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | OM |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 73.4M |
| IPO Year | 2019 | 2020 |
| Metric | BNR | OM |
|---|---|---|
| Price | $15.00 | $4.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.33 |
| AVG Volume (30 Days) | 12.6K | ★ 157.3K |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,476,000.00 |
| Revenue This Year | $111.65 | $9.29 |
| Revenue Next Year | N/A | $10.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $2.80 | $3.00 |
| 52 Week High | $41.72 | $21.98 |
| Indicator | BNR | OM |
|---|---|---|
| Relative Strength Index (RSI) | 34.74 | 54.31 |
| Support Level | $7.99 | $4.06 |
| Resistance Level | $22.50 | $4.88 |
| Average True Range (ATR) | 0.88 | 0.34 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 3.55 | 60.54 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.